Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,646.40
(
1.31%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.09
(
-0.26%
)
Bitcoin
75,650.85
(
-0.17%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Wednesday, 09/18/2019 10:59:46 AM

Wednesday, September 18, 2019 10:59:46 AM

Post# of 257470
IGMS IPOs 12.58M* shares @$16.00:

https://www.globenewswire.com/news-release/2019/09/18/1917109/0/en/IGM-Biosciences-Announces-Pricing-of-Initial-Public-Offering.html

IGM Biosciences is…focused on creating and developing engineered IgM antibodies for the treatment of cancer patients... IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Comments?

The stock is +15% as I’m typing.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today